The progression of carcinoma of the urinary bladder involves migration of cancer epithelia through their surrounding tissue matrix microenvironment. This was experimentally confirmed when a gender-and grade-diverse set of bladder cancer cell lines were cultured in pathomimetic three-dimensional laminin-rich environments. The high-grade cells, particularly female, formed multicellular invasive morphologies in 3D. In comparison, low-and intermediategrade counterparts showed growth-restricted phenotypes. A proteomic approach combining mass spectrometry and bioinformatics analysis identified the estrogen-driven lactose-binding lectin Galectin-1 (GAL-1) as a putative candidate that could drive this invasion. Expression of
Introduction:
Urothelial carcinoma of the bladder (UCB) is a heterogeneous disease and its management is challenging because bladder tumors frequently recur (1) . The rate of recurrence of these tumors has been reported to be due to the result of 'field effect' and/or residual presence of tumor cells following surgery (2) . Although men are about 3 to 4 times more likely to develop bladder cancer during their lifetime than women, the latter often present with more advanced cancers resulting in poorer survival and therapeutic outcomes (3) .
Based on the extent of invasion Bladder tumors may either be classified as non-muscle-invasive (NMIBC) (Ta/T1), and muscle-invasive (MI) (T2/T3). At diagnosis, the majority of bladder cancers are non-muscle-invasive (stage Ta) tumors of low grade. NMIBC frequently recur (50-70%) and only 10-15% progress to invasion. On the other hand, MI tumors are diagnosed de novo and have poorer prognosis (1) . The intra-and inter-tumor heterogeneity of this cancer does not allow it to be prognosed by a single biomarker. Tremendous efforts have been put in identifying a robust set of biomarkers for early diagnosis, patient stratification, treatment selection and outcome and prognosis. However, the highly heterogeneous nature of these tumors precludes success in the field. A previous study from our group had identified multiplex protein signatures for the detection of bladder cancer in voided urine samples. Our biomarker panel consists of 5 robust biomarkers offers unprecedented accuracy for the diagnosis of bladder cancer patients (4) . However, the oligoclonal nature of these tumors where a single clone spreads via intraepithelial migration could also contribute to the heterogeneity of individual bladder cancer. In comparison with advances on the diagnosis of bladder cancer, our understanding of bladder cancer cell migration through the organ stroma during metastasis is still inadequate. Key signaling pathways such as NF-κB and TGFβ have been implicated in the induction of bladder cancer cell migration. Upregulation of the p65, which is involved in heterodimerization of NF-κB, results in movement of cancer cells through the ubiquitinylation and degradation of RhoGDIα (5) . Ablation of TGFβ within a murine model of bladder carcinoma results in poorer invasion and progression of bladder cancer cells along with a concomitant downregulation of mesenchymal markers (and upregulation of epithelial counterparts) (6) .
Interestingly, the levels of a non-canonical IkB kinase, TBK1 have been shown to be upregulated in bladder cancer: pharmacological inhibition of its kinase activity attenuates transwell migration of bladder cancer cells, through a decreased phosphorylation of Akt (7) . In addition, the upregulation of miR-1-3p has been shown to attenuate the proliferation and migration of cancer epithelia through upregulation of the soluble protein SFRP-1 (8) . MiR135a on the other hand, increases proliferation and invasion in a Wnt signaling-dependent manner (9) . These studies have predominantly focused on the signaling dynamics associated with cancer cell migration, which is experimentally investigated through movement of cells across permeable filtration barriers. Invasion seen in solid tumors in vivo involves cells navigating through, and interacting with, their stromal matrix milieu (10); there is scarce information on how the proteins and sugars on the surface of bladder cancer cells may interact with bladder ECM in order to migrate to the outer muscle layers.
Cell line models offer the opportunity to assess and recapitulate the biology of neoplastic cells.
We have recently performed MS-based quantitative proteomic profiling (data not published) of 7 well-characterized neoplastic bladder cell lines (KK47, SW780, RT112, VMCUB-1, T24, J82, and UMUC3), which were matched with tumor grade (G1=KK47, SW780, G2=RT112, VM-CUB-1 and G3=T24, J82) and also grouped into male (KK47, VM-CUB-1, J82) and female (SW780, RT112, T24) cell types. A prominent dysregulated molecule that features within our analysis is Galectin-1 (GAL-1). This observation is congruent with increasing evidence of aberrant cancer cell-surface glycosylations, and cognate changes in lectins: proteins that sense, interact, and signal through, these aberrant glycans (11) . The association of one such galactose-binding lectin: GAL-1 with cancer progression has been widely reported in different tumors type (12) (13) (14) (15) (16) (17) .
Studies have shown that GAL-1 de-regulation affects cell proliferation, adhesion and invasiveness in various tumor types through a host of mechanisms that is dependent on its localization. In the cytoplasm it can interact with oncogenic H-Ras to mediate cell transformation (18) . GAL-1 expression in non-malignant developing mammary epithelia and in breast cancer cells in 3D known to localize within nucleus and induce the expression of genes that code for the expression of proliferation-and invasion-specific proteins (12) . Notably, GAL-1 has also been identified as for a regulator of pre-mRNA splicing (19, 20) . Shen and coworkers showed that the elevated levels of GAL-1 increases proliferation and migration of bladder cancer cells through upregulation of MMP-9 in a JNK-dependent manner (21) . The gene encoding GAL-1, i.e., LGALS1 is known to be regulated by estrogen (22) . In this manuscript, we ask whether elevated levels of GAL-1 expression correlates with a greater invasion of cancer cells through the stromal microenvironment of the bladder. The altered expression of GAL-1 and the genderspecific disparities could be used as a prognostic marker and a possible target for bladder cancer therapy.
MATERIALS AND METHODS

Reagents
All of the chemical reagents were of analytical grade, obtained from commercial suppliers, and used without further purification. The antibodies and reagents used in the study along with their source is mentioned as follows: rabbit polyclonal α 
Cell culture
The following cell lines were used in the study: SW780, RT112, T24, KK47, VM-CUB-1 and J82.
All the cell lines except KK47 were purchased from ATCC. KK47 was obtained from Dr. Seiji 
RT-qPCR
RNA from the 6 cell lines (SW780, RT112, T24, KK47, VM-CUB-1 and J82) was isolated using TRIzol TM reagent as per manufacturer protocol. Isolated RNA was quantified using UV-visible spectrophotometer (NanoDrop TM ). RNA (1µg) was reverse transcribed using Verso™ cDNA synthesis kit (Thermo Scientific AB-1453). All sample were processed at the same time and resulting cDNA was diluted 1:10. Real time PCR with SYBR green detection system (Thermo Fischer Scientific) was performed using StepOnePlus TM real-time PCR system (ABI) and
LGALS1 primers: Forward 5'-TCAAACCTGGAGAGTGCCTT-3' and Reverse 5'-CACACCTCTGCAACACTTCC-3' (Annealing temperature: 60ºC). Appropriate no-RT and no template controls were included in each biological repeat.
Immunohistochemistry
The tissues sections were made from paraffin embedded blocks of bladder cancer patients from Kidwai Memorial Institute of Oncology, Bengaluru with the Institutional Human Ethics Committee approval and informed consent of the patients. The slides were first deparaffinised and then subjected to antigen retrieval in citrate buffer. Thereafter, the tissue sections were quenched using hydrogen peroxidase for 30 minutes and incubated with primary antibody (α-Gal-1 antibody overnight at 4ºC. The sections were then treated with secondary antibody (anti-rabbit IgG conjugated with HRP). The color was then developed using DAB substrate and counterstained with hematoxylin.
Adhesion assay
96 well plate was coated with a thin layer (100 µg/ml) of Matrigel TM in PBS and was allowed to solidify overnight. A total of 5x10 3 cells suspended in DMEM/ supplemented with 10% FBS was added to each well and incubated for 30 minutes at 37ºC in CO 2 incubator. The cells were then fixed with 4% paraformaldehyde and stained with propidium iodide (50 µg/ml) and the fluorescence (535/617 nm) was measured using a plate reader (Tecan infinite M200 Pro™).
Resazurin assay 5x10 3 cells were seeded in each of the 96 well plate and was serum-starved overnight. The cells were then cultured in DMEM (10% FBS) for 24 hours and then treated with resazurin (100 µg/ml) at 37ºC in CO 2 incubator for approximately 1 hour. The cellular proliferation is then assayed by measuring fluorescence at 560/590 nm (Tecan infinite M200 Pro™).
Genetic perturbation of LGALS1
The shRNA clone used to knock out LGALS1 was 5`-
obtained from MISSION shRNA library (TRCN0000057425, Sigma Merck, USA). The plasmid containing the shRNA was packed into lentivirus by packaging vectors (pMD2.G and psPAX2, Addgene, USA (kind gift from Prof. Deepak K Saini)). The plasmids were transfected into 293FT cells (Invitrogen, USA) by Turbofect and cultured in DMEM containing 10% FBS. After 48 hours, the culture medium was filtered using 0.2 µm filter, concentrated using Lenti-X Concentrator (Takara Bio Inc., Japan) and stored at -80 ºC. To transduce T24 cells, 2 x 10 4 cells were cultured in 12 well plate along with lentivirus and polybrene (0.8 µg/ml) for 24 hours. The
LGALS1 knock down cells were selected using puromycin (2 µg/ml).
OTX008 treatment
OTX008 was supplied from Cayman chemicals (CAS no 286936-40-1) and was dissolved in DMSO (stock 10 mM), further diluted in culture medium before in vitro assay.
MTT assay
The IC 50 of T24 cells with OTX008 was determined with MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. 5 x 10 3 cells were seeded in 96 well plate and the cells were treated with appropriate drug concentrations for 24 hours. The formazan crystals, which were formed after the addition of MTT solution were dissolved using DMSO and absorbance was measured at 570 nm using a plate reader (Tecan infinite M200 Pro™).
Statistics
The numerical values of all the experiments were recorded in Excel (Microsoft) and statistical analyses were performed using Graphpad Prism (GraphPad Software, Inc.). The data were analysed using unpaired student's t test or one-way ANOVA. 
RESULTS
Grade
Proteomic and bioinformatic analyses reveal elevated levels of Gal-1 in female grade 3 urothelia
To verify our hypothesis, we analyzed and compared the proteome changes across all six above-mentioned bladder carcinoma cell lines. We used gender and grade filters to identify the differentially regulated proteins. The up regulated proteins that associated best with high-grade female-derived cell lines were subjected to a second filter to identify proteins whose genes were known to be responsive to estrogen (33) . The top three genes in this list encoded for ENO1, CLIC4 and LGALS1 (Fig. 2) . The gene encoding GAL-1 not just has an ERE in its nearpromoter region, it is known to be an estrogen responsive gene (22) . Given its cancerpermissive role and its association with epithelial mesenchymal transition (34), we further focused on a potential relation between Galectin-1 and the invasive-proliferative phenotype in female high-grade bladder cells.
GAL-1 mRNA levels associate with bladder cancer cell invasion in 3D
We next sought to investigate a possible association between LGALS1 gene expression and the morphological phenotypes seen in Fig. 1 . We assayed for the levels of LGALS1 using qPCR and found its mRNA levels to be highest in T24 cells (female grade 3), followed by KK47 (male grade 3), VM-CUB-1 (male grade2), and J82 (male grade 1), and lowest in the epithelial RT112
and SW780 (female grade 1 and 2) (Fig. 3a) . We further used indirect immunocytochemistry to observe the localization of GAL-1 protein in the 3D cultures of bladder cancer cells. In highgrade female cancer cells, we observed a dispersed and overall higher signal for GAL-1 in the matrix surrounding the cells (Fig. 3b) . This extracellular dispersed staining was absent in lower grade cells (as well as in negative control), although also observed in male high-grade cells.
Laminin is a known ligand for GAL-1 (35, 36) . High gene expression for GAL-1 seems to therefore associate with a distinctly extracellular (in addition to cytoplasmic as noted for all the other cells) localization, which also signifies its well-established secretory matricellular functions.
An immunohistochemical comparison of GAL-1 staining showed higher signals in high-grade bladder cancer sections relative to low-grade and 'adjacent-normal' tissues (Fig. 3c) . We therefore chose to investigate whether the inhibition of GAL-1 levels affect bladder tumor development and growth.
GAL-1 inhibition decreases the proliferation of high-grade female cancer cells on lrECM
We compared GAL-1 levels across 6 cell lines that were cultured on top of lrECM scaffolds.
Using the fluorescence of resorufin formed as a result of the reduction of cell-permeable resazurin as readout, we observed that cells with higher levels of GAL-1 showed greater viability in 3D (Fig. 4a) . Pharmacological inhibition of GAL-1 using the calixarene derivative OTX008
(shown to be specific to GAL-1(37,38)) in 3D lrECM scaffolds significantly decreased the ability of T24 cells to form resorufin, suggesting decreased cell proliferation upon attenuation of GAL-1 function ( Fig. 4b ; dose dependent effect of OTX008 on T24 cell viability shown in Fig. S1 ). To further confirm this result, we carried out stable knockdown of GAL-1 using lentiviral transduction of T24 cells with shRNA ( Fig. 4c ; confirmation of knockdown through immunoblotting shown in Fig. S2 ). We observed that T24 cells with impaired levels of GAL-1 were significantly less proliferative when compared to their control counterparts in 3D.
GAL-1 inhibition decreases adhesion of invasive bladder cells to laminin
The inability of early grade bladder cancer cells to form multicellular invasions within their matrix surroundings as seen in Fig. 1 can be explained by an increased affinity to form intercellular adhesions and a concomitant decreased affinity for binding to surrounding matrix. To test this hypothesis, we measured the binding of the six bladder carcinoma cell lines to laminin-rich substrata. The adhesion of cells to lrECM was found to be correlated with GAL-1 levels. T24 cells adhered to the greatest extent (Fig. 5a ). We tested if adhesion was dependent on GAL-1 expression by adding T24 cells to laminin-rich substrata, with or without treatment with OTX008.
We observed that significantly lower number of cells bound to laminin-rich substrata in the presence of OTX008, suggesting that GAL-1 may play a role in helping bladder cells tether better to matrix proteins and facilitate their migration as mesenchymal collectives seen in Fig 1   (Fig. 5b ). T24 cells with stable knockdown of GAL-1 showed decreased adhesion to lrECM confirming that GAL-1 could regulate the interaction of cells with laminin-rich milieu (Fig. 5c ). An increased ability to tether to matrix commonly accompanies transition of cellular phenotype from an epithelial to a mesenchymal morphology (39) . Interestingly, we observed that two cells that showed the greatest expression of GAL-1: T24 and J82, showed no signal for E-cadherin, an epithelial marker whereas N-cadherin was highly upregulated. On the other hand, SW780 and RT112, the cells with low levels of GAL-1 showed high levels of E-cadherin and low levels of Ncadherin (Fig. 5d) .
Inhibition of GAL-1 reverses the invasive phenotype of high-grade female cancer cells
We next sought to investigate the cumulative effect of the regulation by GAL-1 of bladder cancer cell proliferation and matrix adhesion. We probed the effect of GAL-1 expression and function within pathotypic 3D culture assays. The ability of T24 cells to display stellate invasive morphologies when cultured in lrECM typifies the ability of urothelial cancer cells to be able to breach the basement membrane barrier to reach the stromal compartment of the bladder. When we inhibited GAL-1 function within T24 cells, using OTX008, the cells were unable to invasively explore lrECM scaffolds. Rather, they reverted to a spheroid-like multicellular cluster phenotype that is reminiscent of low-grade cellular behavior (Fig. 6a) . This was confirmed in T24 cells with stable knockdown of GAL-1, which also exhibited non-invasive morphologies in 3D (Fig 6b) .
We further tested the role of GAL-1 in migration within stroma, which is rich in Type 1 Collagen.
When cells were cultured within Type 1 collagen scaffolds, T24 cells were able to migrate by forming cellular trails through the collagen-rich milieu, ultimately forming a web-like network (Fig. 6c) . However, when treated with OTX008, or upon GAL-1 knockdown, the T24 cells remained as single cells embedded within the matrix ( Fig. 6c and d) .
GAL-1 regulates the levels of free cell surface sialic acid to mediate bladder cancer cell migration
The regulation of migration and ultimately, metastasis of cancer cells has been linked to cell surface expression of glycans (15, 40, 41) . There is rich literature specifically on sialic acid (Sial), the levels of which have been reported to modulate cell motility impacting invasiveness (12, 42, 43) . When we stained the high-gradeT24 cells for Sialic acid conjugates (Sial) using FITC-conjugated Limulus polyphemus agglutinin (LPA), we found that the surface staining of
Sial was sparse in comparison with robust levels of in female intermediate-and low-grade cells (Fig. 7a) . To our surprise, upon knockdown of GAL-1, Sial levels showed an increase with respect to scrambled and wild type control T24 cells ( Fig. 7b and c) . We sought to ask whether the effect of GAL-1 levels on Sial levels extended to other cell surface glycans. Upon staining for α 1,3-and 1,6-fucose (using Aleuria Aurantia lectin), O-linked conjugates (using Jacalin), biantennary N-glycans with bisecting N-acetylglucosamine (GlcNAc) (using Phaseolus vulgaris Erythroagglutinin (PHA-E)), and non-sialylated tri-and tetraantennary N-glycans (using Phaseolus vulgaris Leucoagglutinin (PHA-L)) using flurophore conjugated lectins, we found little difference between glycan levels in control and GAL-1 depleted T24 cells, suggesting our demonstration of the effect of GAL-1 on Sial levels was glycan-specific (Fig. S3) . Finally, when control T24 cells were cultured within lrECM and medium was supplemented with sialic acids, the cells showed a decreased tendency for invasive morphogenesis, phenocopying the effect on the invasive phenotype of attenuated GAL-1 function and expression (Fig. 7d) 
DISCUSSION
The demonstration of the differences between the glycocalyces of normal and cancerous cells are as old as the demonstration that specific genes encode proteins that lead to oncogenesis (oncogenes) or suppression of neoplastic transformation (tumor suppressors) (44, 45) .
Glycocalyces, consisting of glycan structures conjugated to proteins and lipids regulate both the mechano-and chemo-transductive cues within cells (40, 41, 46) . Such glycoconjugates are recognized by-and function in interaction with-, endogenously expressed lectins, of which one of the best-known classes is the β lactoside-binding lectins. It is therefore not surprising that Galectin-1, the first galectin to be characterized, is known to play an important role in cellular homeostasis, neoplastic progression and metastasis in a variety of tissues and organs (47) .
GAL-1 emerged as a putative candidate in this present study when we applied gender-and grade-based selection filters on a proteomic analysis of a set of six cell lines of low-, intermediate-and high grade, and male and female gender. When we asked which proteins would be highest in the high grade female bladder cancer cell lines, and whose gene expression would be driven by estrogen, GAL-1 was one of the three highest upregulated proteins that satisfied our selection criteria.
In fact, we observed that both the invasiveness of multicellular phenotype in 3D as well as GAL- A recent study on GAL-1 suggests that it increases the proliferation and invasion of two urothelial cancer lines through upregulation of MMP-9 through Ras-Raf-MAPK-JNK pathway (21) . We have built on, and tested, these observations in the context of cell-matrix interactions:
proliferation and invasion of bladder cancer cell lines in 3D matrix environments by and large tracks the expression in the cells of GAL-1 mRNA. Notably, the expression of GAL-1 is also congruent with the adhesion of cells to the matrix, which is in keeping with the matricellular roles of GAL-1 (48, 49) . The female high-grade cells showed higher proliferation, adhesion and invasion within laminin-rich matrix environments. Abrogation of GAL-1 both pharmacologically and using RNAi manages to reverse all these phenotypes. We have examined the subcellular localization of Gal-1: whereas Gal-1 in low grade cancer cells is restricted to the cell surface, it shows a more promiscuous localization in high grade cells with some localization in the nucleus as well as in the extracellular milieu. Such diffuse localization is associated with carcinomatosis (12) and a recent report suggests nuclear Gal-1 binds to and inhibits the tumor suppressive function of Foxp3 (50).
Given our focus on the understanding of the interactions between cancer cells and their microenvironment, we investigated the effect of altering GAL-1 levels on cell surface glycome.
Sialic acids which typically are present at the terminal ends of N-and O-linked glycosylation are known to be deregulated in cancers: cancer glycocalyces are typically hypersialylated (42, 43) .
Intriguingly, a report suggests that the 2,6-sialyltransferase ST6GAL1 gets epigenetically inactivated in bladder cancer (51) . Our results are in concurrence with the report: we see lower staining of glycocalyx with a lectin that binds to diverse linkages of sialic acids. To our surprise, knocking down GAL-1 results in an increase in sialic acid signals as reported by lectin binding.
These results may be interpreted in two ways: GAL-1 may transcriptionally regulate the expression of genes involved in sialic acid biosynthesis. On the other hand, when GAL-1 levels are high and localized extracellularly, they may mask the sialic acids (predominantly 2,3-linked) from binding to LPA resulting in weaker signals from the latter. Our demonstration that addition of free sialic acid (which would not act as a sink for unbound GAL-1) can nevertheless revert the invasive phenotype of T24 cells seems to tilt our opinion towards the first conjecture, i.e., invasion of bladder cancer cells requires lower expression of sialic acids that is mediated endogenously by GAL-1. In the future, we will investigate if GAL-1 may alter Sialic acid levels through promoter methylation of specific sialyltransferases.
Our results suggest that the dysmorphic multicellular phenotype we observed for high-grade bladder cancer could be a cumulative effect of GAL-1 on proliferation, and matrix adhesion of cancer epithelia. The pharmacological and genetic inhibition of Gal-1 was able to arrest the growth and invasion of high-grade invasive cells. It is pertinent to ask if the higher level of GAL-1 is a gender-specific prognosticator of urothelial cancer progression? In order to answer this, we examined TCGA (The cancer Genome Atlas) data stratified on the basis of gender and grades. Whereas high-grade bladder cancer tissues showed significantly higher levels of Gal-1 mRNA in comparison with lower grades, the expression of Gal-1 mRNA in female tissues was not significantly higher than their male counterparts (Fig S4) . This could be explained by increase in estrogen levels in male patients with age (52) . Therefore, high Gal-1 expression driven by estrogen in carcinomatous urothelia is potentially responsible for the debilitative outcome of the cancer in both men and women but particularly in women. Our functional studies provide a deeper insight into the Gal-1 role in advancing the tumor progression and invasion.
Silencing Gal-1 could be a novel therapeutic approach in the management of more advanced bladder cancer in women. For all bar graphs, error bars represent SEM. Statistical significance computed using unpaired parametric t-test is given by *P < 0.05; **P < 0.01. For all bar graphs, error bars represent SEM. Statistical significance computed using one-way ANOVA for 4a and unpaired parametric t-test for 4 b and c is given by *P < 0.05; **P < 0.01, ****P < 0.0001. Statistical significance computed using one-way ANOVA for 5a and unpaired parametric t-test for 5b and c is given by *P < 0.05; **P < 0.01. α -1,6-and 1,3-linked fucose (using Aleuria Aurantia lectin (AAL)), O-linked conjugates (using Jacalin), biantennary N-glycans with bisecting N-acetylglucosamine (GlcNAc) (using Phaseolus vulgaris Erythroagglutinin (PHA-E)), and non-sialylated tri-and tetraantennary N-glycans (using Phaseolus vulgaris Leucoagglutinin (PHA-L)) (Scale bar, 100 μ m) Figure S4 : The TPM (Transcript Per Million) value of LGALS1 gene was obtained from TCGA (The Cancer Genome Atlas) (grade 2 (33 females and 97 males), grade 3 (39 females and 101 males) and grade 4 (35 females and 98 males)) was plotted and the resulting graph depicts significant increase in GAL-1 transcript levels with increase in grades both in female and male patients. Statistical significance computed using one-way ANOVA. For all bar graphs, error bars represent SEM.
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